Stock Earnings

Question 1

What are JCR Pharmaceuticals Co Ltd's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), JCR Pharmaceuticals Co Ltd has a total asset of $104,855, Net loss of $-4,759

Question 2

What are the key financial ratios for JCRRF?

Accepted Answer

JCR Pharmaceuticals Co Ltd's Current ratio is 1.81, has a Net margin is -14.38, sales per share of $267.08.

Question 3

How is JCR Pharmaceuticals Co Ltd's revenue broken down by segment or geography?

Accepted Answer

JCR Pharmaceuticals Co Ltd largest revenue segment is Pharmaceutical, at a revenue of 33,072,000,000 in the most earnings release.For geography, Japan is the primary market for JCR Pharmaceuticals Co Ltd, at a revenue of 33,072,000,000.

Question 4

Is JCR Pharmaceuticals Co Ltd profitable?

Accepted Answer

no, according to the latest financial statements, JCR Pharmaceuticals Co Ltd has a net loss of $-4,759

Question 5

Does JCR Pharmaceuticals Co Ltd have any liabilities?

Accepted Answer

yes, JCR Pharmaceuticals Co Ltd has liability of 57,812

Question 6

How many outstanding shares for JCR Pharmaceuticals Co Ltd?

Accepted Answer

JCR Pharmaceuticals Co Ltd has a total outstanding shares of 121.83

Breakdown	TTM	03/31/2025	03/31/2024	03/31/2023	03/31/2022	03/31/2021
Revenue	37,777	33,072	42,871	34,343	51,082	30,085
Revenue Growth (YoY)	7%	-23%	25%	-33%	70%	21%
Cost of Revenue	11,326	11,333	11,620	8,886	10,461	7,812
Gross Profit	26,451	21,739	31,251	25,457	40,621	22,273
Selling, General & Admin	29,982	12,958	12,485	11,678	13,511	8,643
Research & Development	--	15,431	11,234	8,802	7,175	5,360
Operating Expenses	30,153	28,580	23,720	20,482	20,688	14,004
Other Non Operating Income (Expenses)	90	35	5	59	38	23
Pretax Income	-3,317	-6,414	7,244	5,412	19,404	8,653
Income Tax Expense	-1,009	-1,718	1,707	1,625	4,886	1,764
Net Income	-2,358	-4,759	5,507	3,772	14,507	6,892
Net Income Growth	440%	-186%	46%	-74%	110%	157%
Shares Outstanding (Diluted)	121.95	123.82	125.39	124.83	124.2	124.13
Shares Change (YoY)	-3%	-1%	0%	1%	0%	0%
EPS (Diluted)	-19.32	-38.43	43.91	30.21	116.79	55.52
EPS Growth	453%	-188%	45%	-74%	110%	157%
Free Cash Flow	-9,859	-15,373	7,217	-14,059	-2,044	2,813
Free Cash Flow Per Share	-80.83	-124.15	57.55	-112.61	-16.45	22.66
Gross Margin	70.01%	65.73%	72.89%	74.12%	79.52%	74.03%
Operating Margin	-9.79%	-20.68%	17.56%	14.48%	39.02%	27.48%
Profit Margin	-6.24%	-14.38%	12.84%	10.98%	28.39%	22.9%
Free Cash Flow Margin	-26.09%	-46.48%	16.83%	-40.93%	-4%	9.35%
EBITDA	-536	-3,467	10,728	6,972	21,878	10,161
EBITDA Margin	-1.41%	-10.48%	25.02%	20.3%	42.82%	33.77%
D&A For EBITDA	3,166	3,374	3,197	1,997	1,945	1,892
EBIT	-3,702	-6,841	7,531	4,975	19,933	8,269
EBIT Margin	-9.79%	-20.68%	17.56%	14.48%	39.02%	27.48%
Effective Tax Rate	30.41%	26.78%	23.56%	30.02%	25.18%	20.38%

JCR Pharmaceuticals Co Ltd (JCRRF) Price

JCRRF Stock Price Chart

JCRRF Income

Follow-Up Questions